Difference between revisions of "Alvarez Diego F"

From Bioblast
Jump to navigation Jump to search
Line 16: Line 16:
== Participated at ==
== Participated at ==
::::* [[MiPNet27.02 IOC153 Innsbruck AT]]
::::* [[MiPNet27.02 IOC153 Innsbruck AT]]
::::* [[Bioblast 2022|Bioblast 2022: BEC Inaugural Conference]]

Latest revision as of 10:44, 6 July 2022

Name Alvarez Diego F, MD, PhD
Institution Department of Physiology & Pharmacology
Sam Houston State University
College of Osteopathic Medicine
Texas, US
Address 925 City Central Avenue, TX 77304
City Conroe
State/Province Texas (TX)
Country USA
Email diego.alvarez@shsu.edu
Weblink ORCID ID
O2k-Network Lab



Audia 2018 Basic Res Cardiol2018Audia JP, Yang XM, Crockett ES, Housley N, Haq EU, O'Donnell K, Cohen MV, Downey JM, Alvarez DF (2018) Caspase‑1 inhibition by VX‑765 administered at reperfusion in P2Y12 receptor antagonist‑treated rats provides long‑term reduction in myocardial infarct size and preservation of ventricular function. Basic Res Cardiol 113:32.
Yuzefovych 2013 Endocrinology2013Yuzefovych LV, Schuler AM, Chen J, Alvarez DF, Eide L, Ledoux SP, Wilson GL, Rachek LI (2013) Alteration of mitochondrial function and insulin sensitivity in primary mouse skeletal muscle cells isolated from transgenic and knockout mice: role of OGG1. Endocrinology 154:2640-9.


Alvarez 2022 Bioblast20222022Participant: Bioblast 2022 and NextGen-O2k Workshop.

Participated at